ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,053Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 546

$480K Total Retail Price of All Prescriptions

Rank: 58 out of 546

312 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 312 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 312 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,749 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 414 379 1 2
OMEPRAZOLE 314 256 2 4
LISINOPRIL 302 264 3 1
ATORVASTATIN CALCIUM 220 186 4 11
FUROSEMIDE 206 190 5 5
POTASSIUM CHLORIDE 190 189 6 30
ATENOLOL 182 169 7 12
SYNTHROID 162 147 8 166
HYDROCODONE-ACETAMINOPHEN 160 110 S3 9 8
LEVOTHYROXINE SODIUM 158 133 10 3
AMLODIPINE BESYLATE 156 138 11 9
HYDROCHLOROTHIAZIDE 144 131 12 7
CRESTOR 144 108 12 36
LOSARTAN POTASSIUM 141 136 14 24
METOPROLOL TARTRATE 140 136 15 6
FAMOTIDINE 135 126 16 53
METFORMIN HCL ER 121 108 17 74
WARFARIN SODIUM 116 116 18 13
SERTRALINE HCL 116 115 18 14
CITALOPRAM HBR 101 98 20 21
PANTOPRAZOLE SODIUM 98 86 21 18
METOPROLOL SUCCINATE 92 89 22 17
NEXIUM 85 49 23 52
ISOSORBIDE MONONITRATE ER 75 68 24 32
JANUVIA 74 60 25 79
OXYCODONE HCL 68 20 S2 26 15
DILTIAZEM 24HR CD 65 53 27 91
TRAZODONE HCL 62 47 28 25
TRAMADOL HCL 62 57 28 19
AZITHROMYCIN 62 49 28 55
LIDODERM 61 51 31 73
EVISTA 59 59 32 158
PRAVASTATIN SODIUM 58 58 33 33
GABAPENTIN 57 32 34 16
FLUOXETINE HCL 55 51 35 39
CYCLOBENZAPRINE HCL 55 25 R 35 34
ADVAIR DISKUS 52 46 37 20
PROAIR HFA 52 27 37 27
ALLOPURINOL 51 35 39 41
MECLIZINE HCL 51 50 39 131
GLYBURIDE 51 48 R 39 45
RANITIDINE HCL 50 42 42 23
ZOLPIDEM TARTRATE 50 49 42 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.